BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17611077)

  • 1. Nicotine inhibits apoptosis induced by cisplatin in human oral cancer cells.
    Xu J; Huang H; Pan C; Zhang B; Liu X; Zhang L
    Int J Oral Maxillofac Surg; 2007 Aug; 36(8):739-44. PubMed ID: 17611077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to cisplatin-induced apoptosis via PI3K-dependent survivin expression in a rat hepatoma cell line.
    Asechi H; Hatano E; Nitta T; Tada M; Iwaisako K; Tamaki N; Nagata H; Narita M; Yanagida A; Ikai I; Uemoto S
    Int J Oncol; 2010 Jul; 37(1):89-96. PubMed ID: 20514400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt.
    Liu B; Shi ZL; Feng J; Tao HM
    Cell Biol Int; 2008 May; 32(5):494-501. PubMed ID: 18078766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of survivin expression enhances sensitivity of cultured uveal melanoma cells to cisplatin treatment.
    Li H; Niederkorn JY; Neelam S; Alizadeh H
    Exp Eye Res; 2006 Jul; 83(1):176-82. PubMed ID: 16584731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin.
    Dasgupta P; Kinkade R; Joshi B; Decook C; Haura E; Chellappan S
    Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6332-7. PubMed ID: 16601104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis.
    Tang C; Lu YH; Xie JH; Wang F; Zou JN; Yang JS; Xing YY; Xi T
    Anticancer Drugs; 2009 Apr; 20(4):249-58. PubMed ID: 19174695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression.
    Tang Y; Zhao DY; Elliott S; Zhao W; Curiel TJ; Beckman BS; Burow ME
    Int J Oncol; 2007 Oct; 31(4):705-11. PubMed ID: 17786300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatidylinositol-3-OH kinase/AKT and survivin pathways as critical targets for geranylgeranyltransferase I inhibitor-induced apoptosis.
    Dan HC; Jiang K; Coppola D; Hamilton A; Nicosia SV; Sebti SM; Cheng JQ
    Oncogene; 2004 Jan; 23(3):706-15. PubMed ID: 14737105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells.
    Wang J; Yang L; Yang J; Kuropatwinski K; Wang W; Liu XQ; Hauser J; Brattain MG
    Cancer Res; 2008 May; 68(9):3152-60. PubMed ID: 18451140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced susceptibility to apoptosis of oral squamous cell carcinoma cells subjected to combined treatment with anticancer drugs and phosphatidylinositol 3-kinase inhibitors.
    Iwase M; Yoshiba S; Uchid M; Takaoka S; Kurihara Y; Ito D; Hatori M; Shintani S
    Int J Oncol; 2007 Nov; 31(5):1141-7. PubMed ID: 17912441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma.
    Huang Y; Hua K; Zhou X; Jin H; Chen X; Lu X; Yu Y; Zha X; Feng Y
    Cell Res; 2008 Jul; 18(7):780-91. PubMed ID: 18574502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survivin plays as a resistant factor against tamoxifen-induced apoptosis in human breast cancer cells.
    Moriai R; Tsuji N; Moriai M; Kobayashi D; Watanabe N
    Breast Cancer Res Treat; 2009 Sep; 117(2):261-71. PubMed ID: 18815881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels.
    Lu M; Strohecker A; Chen F; Kwan T; Bosman J; Jordan VC; Cryns VL
    Clin Cancer Res; 2008 May; 14(10):3168-76. PubMed ID: 18483385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine Inhibits Cisplatin-Induced Apoptosis via Regulating α5-nAChR/AKT Signaling in Human Gastric Cancer Cells.
    Jia Y; Sun H; Wu H; Zhang H; Zhang X; Xiao D; Ma X; Wang Y
    PLoS One; 2016; 11(2):e0149120. PubMed ID: 26909550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Akt induces significant downregulation of survivin and cytotoxicity in human multiple myeloma cells.
    Hideshima T; Catley L; Raje N; Chauhan D; Podar K; Mitsiades C; Tai YT; Vallet S; Kiziltepe T; Ocio E; Ikeda H; Okawa Y; Hideshima H; Munshi NC; Yasui H; Richardson PG; Anderson KC
    Br J Haematol; 2007 Sep; 138(6):783-91. PubMed ID: 17760810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implication of AMP-activated protein kinase and Akt-regulated survivin in lung cancer chemopreventive activities of deguelin.
    Jin Q; Feng L; Behrens C; Bekele BN; Wistuba II; Hong WK; Lee HY
    Cancer Res; 2007 Dec; 67(24):11630-9. PubMed ID: 18089792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine stimulates proliferation and inhibits apoptosis in colon cancer cell lines through activation of survival pathways.
    Cucina A; Dinicola S; Coluccia P; Proietti S; D'Anselmi F; Pasqualato A; Bizzarri M
    J Surg Res; 2012 Nov; 178(1):233-41. PubMed ID: 22520577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine promotes cell proliferation and induces resistance to cisplatin by α7 nicotinic acetylcholine receptor‑mediated activation in Raw264.7 and El4 cells.
    Wang YY; Liu Y; Ni XY; Bai ZH; Chen QY; Zhang Y; Gao FG
    Oncol Rep; 2014 Mar; 31(3):1480-8. PubMed ID: 24399025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COX-independent antineoplastic effects of sulindac in oral cancer are mediated by survivin down-regulation.
    Scheper MA; Sauk JJ; Nikitakis NG
    Anticancer Res; 2006; 26(6B):4103-13. PubMed ID: 17201121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting survivin via PI3K but not c-akt/PKB by anticancer drugs in immature neutrophils.
    Martinelli S; Kostylina G; Niggli V; Baumann C; Fey MF; Wendel HG; Lowe SW; Yousefi S; Simon HU
    Oncogene; 2006 Nov; 25(52):6915-23. PubMed ID: 16715127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.